-
-
-
-
-
-
-
Telesis Bio Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
-
-
-
-
-
-
-
Translate Bio Announces Second Quarter 2021 Financial ResultsĀ and Provides Corporate Update
-
-
-
-
-
-
-
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
-
-
-
-
-
-
-
Sanofi and Translate Bio Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
-
-
-
-
-
-
-
Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies
-
-
-
-
-
-
-
Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

